PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025

03 10月 2024 08:00:43 条件 Nasdaq GlobeNewswire

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

26 9月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

09 9月 2024 16:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

13 8月 2024 09:46:30 条件 NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

12 8月 2024 09:45:52 条件 NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

09 8月 2024 15:55:27 条件 NetDania Notify

Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey

09 8月 2024 15:21:31 条件 Nasdaq GlobeNewswire

Pacira BioSciences Reports Second Quarter 2024 Financial Results

30 7月 2024 16:00:00 条件 Nasdaq GlobeNewswire

Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024

23 7月 2024 08:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

19 7月 2024 09:53:27 条件 NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

18 7月 2024 15:24:48 条件 NetDania Notify

Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025

10 7月 2024 16:19:14 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

10 7月 2024 12:43:22 条件 NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

09 7月 2024 09:45:29 条件 NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

02 7月 2024 09:54:55 条件 NetDania Notify

Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference

30 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029

10 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes

08 5月 2024 16:05:14 条件 Nasdaq GlobeNewswire

Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program

07 5月 2024 16:00:00 条件 Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

07 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire